+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Palatin Technologies Inc - logo

Palatin Technologies is a biopharmaceutical company that develops targeted, receptor-specific peptide therapeutics for the treatment of various diseases in the United States. The company’s leading product is Bremelanotide, which is used to treat hypoactive sexual desire disorder (HSDD). It has completed pivotal Phase 3 clinical trials. Palatin also has development programs or drug candidates for inflammatory disease indications, heart failure and fibrosis. It was founded in 1986 and is based in Cranbury, New Jersey.

Ulcerative Colitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Ulcerative Colitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 714 Pages
  • Global
From
Ulcerative Colitis - Pipeline Insight, 2024 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 240 Pages
  • Global
From
Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 176 Pages
  • Global
From
Obesity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Obesity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 643 Pages
  • Global
From
Female Sexual Dysfunction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Female Sexual Dysfunction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 69 Pages
  • Global
From
Female Hypoactive Sexual Desire Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Female Hypoactive Sexual Desire Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 51 Pages
  • Global
From
Ulcerative Colitis - Pipeline Review, H2 2020 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 779 Pages
  • Global
From
Type 2 Diabetes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Type 2 Diabetes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 1127 Pages
  • Global
From
Global Female Sexual Dysfunction Treatment Market 2023-2027 - Product Thumbnail Image

Global Female Sexual Dysfunction Treatment Market 2023-2027

  • Report
  • November 2022
  • 120 Pages
  • Global
From
Diabetic Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Diabetic Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 286 Pages
  • Global
From
Global Peptide Therapeutics Market, Drug Dosage, Price & Clinical Trials Insight 2029 - Product Thumbnail Image

Global Peptide Therapeutics Market, Drug Dosage, Price & Clinical Trials Insight 2029

  • Report
  • November 2023
  • 1800 Pages
  • Global
From
Myocardial Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Myocardial Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 53 Pages
  • Global
From
Melanocortin 4 Receptor (MC4R) Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Melanocortin 4 Receptor (MC4R) Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Uveitis - Pipeline Review, H2 2020 - Product Thumbnail Image

Uveitis - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 266 Pages
  • Global
From
Uveitis - Global Drug Forecast and Market Analysis to 2029 - Product Thumbnail Image

Uveitis - Global Drug Forecast and Market Analysis to 2029

  • Report
  • June 2021
  • Global
From
Diabetic Retinopathy - Pipeline Insight, 2024 - Product Thumbnail Image

Diabetic Retinopathy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 210 Pages
  • Global
From
Obesity - Pipeline Review, H2 2020 - Product Thumbnail Image

Obesity - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 640 Pages
  • Global
From
LATAM Hypoactive Sexual Desire Disorder Treatment Market by Treatment Type, Sales Channel: Regional Opportunity Analysis and Industry Forecast, 2020-2027 - Product Thumbnail Image

LATAM Hypoactive Sexual Desire Disorder Treatment Market by Treatment Type, Sales Channel: Regional Opportunity Analysis and Industry Forecast, 2020-2027

  • Report
  • December 2020
  • 145 Pages
  • Global
From
Dry Eye Syndrome Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2018-2028 - Product Thumbnail Image

Dry Eye Syndrome Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2018-2028

  • Drug Pipelines
  • December 2022
  • 123 Pages
  • Global
From
Keratoconjunctivitis sicca (Dry Eye) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Keratoconjunctivitis sicca (Dry Eye) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 292 Pages
  • Global
From
Loading Indicator